Pre-filled injection device with extendable post-injection needle guard
By designing a pre-filled injection device, and utilizing a combination of end components, reservoir, double-ended needle, and shield assembly, the problems of reusability and needlestick injuries in uncontrolled environments are solved. This enables automatic needle coverage and appropriate dosage application, providing a safe and economical injection solution.
Patent Information
- Application Number
- CN202580029869.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-02-22
- Filing Date
- 2025-02-18
- Publication Date
- 2026-11-17
AI Technical Summary
Existing injection devices may be reused in uncontrolled environments, leading to safety issues and disease transmission. They also pose a high risk of needlestick injury after injection, and the current design does not automatically cover the needle, posing a risk of improper use and dosage measurement errors.
A pre-filled injection device is designed, including an end member, a reservoir, a double-ended needle, a shield assembly, and a biasing member. The fluid is injected by reducing the reservoir volume by pressing the membrane, and the needle is automatically covered after use. The biasing member and the shield assembly achieve automatic protection of the needle.
It achieves automatic needle covering after injection, preventing reuse, reducing the risk of needlestick injuries, and ensuring appropriate drug dosage, making it a safe and economical injection solution suitable for uncontrolled environments.
Smart Images

Figure CN123125003A_ABST
Abstract
Description
Cross-reference to related applications
[0001] This application claims priority to European Patent Application No. 24305291.7, filed on February 22, 2024, entitled “Pre-fillable Injection Device With Extendable Post-injection Needle Shield”, the disclosure of which is incorporated herein by reference in its entirety.
[0002] Background of the Invention Field of the Invention This disclosure generally relates to disposable injection devices, and more specifically to disposable injection devices having features that automatically prevent reuse of the device and protect the needle of the device after injection.
[0003] Description of related technologies Syringes and other injection devices are used in a variety of environments to administer fluids to patients. When used by trained healthcare professionals in controlled healthcare settings, these devices provide an effective and cost-efficient solution for administering vaccines or other medications to patients. However, it should be recognized that safety and / or misuse issues can arise when injection devices are used in less controlled environments. One potential safety issue with injection devices such as syringes is their reuse, which often occurs after inadequate cleaning and sterilization, particularly in developing countries, where the reuse of contaminated syringes can lead to disease outbreaks or infections. Another potential safety issue with syringes is needlestick injuries that can occur after use, where the user accidentally pricks themselves with the syringe needle after administering fluid to a patient, potentially exposing themselves to a contaminated syringe and potentially transmissible bloodborne diseases. In addition to safety concerns, it has been recognized that errors can occur in determining and administering the appropriate dose of medication to a patient if the user is untrained and / or administering the medication in a chaotic environment.
[0004] To address some of the challenges mentioned above, many syringes and injection devices have been redesigned to incorporate features that can resolve safety and / or misuse issues. As an example, some syringes or injection devices have been designed to incorporate automatic or semi-automatic needle covering after use, or improvements to prevent the syringe or injection device from breaking down after a single use. These so-called safety syringes / devices are inevitably much more expensive than standard syringes and therefore are not a universal solution to these problems, especially in developing countries where such syringes may be unaffordable.
[0005] In addition to this type of safe syringe / device, attempts have been made to provide inexpensive, single-use, self-destructive, pre-filled devices, which may be best suited for use in developing countries. An example of such a device is the "Uniject™" pre-filled injection device manufactured by Becton Dickinson and Company. The Uniject comprises a plastic blister or reservoir (containing the medication) and an attached needle, wherein the device delivers a predicted dose of medication to the patient, and the device includes features located thereon to prevent reuse. While the Uniject device thus provides an ideal low-cost solution for developing countries and / or for large-scale vaccination campaigns, existing designs of the device do not provide a mechanism for automatically or semi-automatically refilling the needle after use.
[0006] Therefore, there is a need in the art for pre-filled injection devices that effectively disable the device after initial use and automatically cover the needle after use, while also providing patients with a predicted dose of medication, all of which are housed in an affordable device designed for uncontrolled environments. Summary of the Invention
[0007] This document provides a pre-filled injection device. The injection device includes an end member grippable by a user and having a distal and a proximal end, the end member including a membrane. The injection device also includes a reservoir defined within the end member and pre-filled with fluid, wherein the reservoir is at least partially formed by the membrane, and the membrane is pressable by the user to reduce the volume of the reservoir, thereby forcing the fluid out of the reservoir. The injection device further includes: a port and a hub disposed on and at the distal end of the end member and configured to provide an inlet to the reservoir; and a double-ended needle held by the hub and having a proximal end positioned within the port and a distal end extending from the port, the double-ended needle being movable from a first position to a second position, in which the proximal end is separated from the reservoir, and in the second position, the proximal end is positioned to pierce the reservoir to achieve fluid communication between the needle and the reservoir. The injection device further includes: a shield assembly positioned at the distal end of the end member and movable distally from a retracted position to an advanced position, wherein when the shield assembly is in the retracted position, the distal end of the needle extends distally over the shield assembly, and when the shield assembly is in the advanced position, the distal end of the needle is covered by the shield assembly; and a biasing member configured to actuate the shield assembly from the retracted position to the advanced position.
[0008] In some embodiments, the pre-filled injection device includes a removable needle cap that can be pressed in a proximal direction to actuate the double-ended needle from the first position to the second position.
[0009] In some embodiments, after the double-ended needle is actuated from the first position to the second position, the removable needle cap is removed to allow the distal end of the needle to be inserted into the patient.
[0010] In some embodiments, the port includes a safety port comprising: a port body defining a cavity and having an open distal end and a proximal end, an end cap at the proximal end of the port body, wherein the port body has a pair of slots formed therein extending longitudinally along the port body, and an opening formed in the port body on a side of the port body at a location between the pair of slots; and a coupling member positioned at the proximal end of the port body and configured to couple the safety port to the end member.
[0011] In some embodiments, the shield assembly includes a needle chamber positionable within the cavity, the needle chamber comprising: a cylindrical body having an open proximal end, wherein the cylindrical body has a plurality of slots formed therein extending longitudinally along the cylindrical body, and an annular flange formed at a distal end of the cylindrical body, the annular flange extending radially inward and forming a seat; and a cantilevered flexible protrusion coupled to the distal end of the cylindrical body, the flexible protrusion having a button thereon sized to be received within an opening of the port body. The shield assembly also includes a pair of side members configured to movably couple the needle chamber to the safety port, each of the pair of side members including a pin and a locking protrusion engaging with a pair of slots of the port body and the plurality of slots of the cylindrical body to allow longitudinal movement of the pair of side members and the needle chamber relative to the safety port. The biasing member is positioned between the safety port and the needle chamber and is held by the end cap and the seat. The biasing member is configured to translate the needle chamber distally from the safety port, thereby transferring the shield assembly from the retracted position to the forward position.
[0012] In some embodiments, when the flexible protrusion is pressed inward, the button disengages from the opening to unlock the needle chamber from the safety port, thereby releasing the biasing member and enabling the needle chamber to move distally from the safety port.
[0013] In some embodiments, the engagement of these pins with a pair of slots in the port body and a plurality of slots in the cylindrical body restricts the distal movement of the needle chamber from the safety port to prevent excessive slippage.
[0014] In some embodiments, once the shield assembly is switched to the forward position, the locking protrusions lock the needle chamber in place and prevent it from being switched back to the retracted position.
[0015] In some embodiments, the removable needle cap is attached to the distal end of the cylindrical body of the needle chamber.
[0016] In some embodiments, the pre-filled injection device includes a guide member coupled to the port, wherein the guide member includes an elongated frame attached to the port and extending across the width of the end member. The elongated frame includes a first through-hole positioned adjacent to a first edge of the elongated frame, a second through-hole positioned adjacent to a second edge of the elongated frame, and a third through-hole located at the center of the elongated frame and aligned with the port, wherein a seat is formed around the third through-hole on a distally facing side of the elongated frame. The guide member also includes a pair of release protrusions formed on opposite sides of the elongated frame and adjacent to the first and second through-holes.
[0017] In some embodiments, the shield assembly includes a U-shaped sliding member comprising: a cross-bracket having a first end and a second end; a first sliding guide positioned at the first end of the cross-bracket and extending proximally from the cross-bracket, the first sliding guide being configured to slide through the first through-hole; a second sliding guide positioned at the second end of the cross-bracket and extending proximally from the cross-bracket, the second sliding guide being configured to slide through the second through-hole; a receiving portion located at the center of the cross-bracket; and a safety chamber located within the receiving portion, the safety chamber having an open proximal end and an open distal end. A biasing member is positioned between the guide member and the U-shaped sliding member and held by the seat and the receiving portion, the biasing member being configured to translate the U-shaped sliding member distally away from the guide member, thereby transitioning the shield assembly from the retracted position to the forward position.
[0018] In some embodiments, each of the first sliding guide and the second sliding guide includes: a pair of distal support protrusions; and a pair of proximal support protrusions; wherein each of the pair of distal support protrusions is capable of engaging a notch formed in a corresponding one of the first through hole and the second through hole; and wherein the pair of proximal support protrusions is capable of engaging a proximal side and a distal side of the elongated frame.
[0019] In some embodiments, when the shield assembly is in the retracted position, one of the pair of distal support protrusions on each of the first and second sliding guides engages with a notch in a corresponding one of the first and second through holes to lock the U-shaped sliding member in the retracted position.
[0020] In some embodiments, when the pair of release protrusions are pressed inward, one of the pair of distal support protrusions on each of the first and second sliding guide buttons disengages from the notch to unlock the U-shaped sliding member from the guide member, thereby releasing the bias member and enabling the U-shaped sliding member to move distally away from the guide member.
[0021] In some embodiments, when the shield assembly is in the forward position, the pair of proximal support protrusions engage with the proximal and distal sides of the elongated frame to lock the U-shaped sliding member in place and prevent it from reverting to the retracted position.
[0022] In some embodiments, with the shield assembly in the forward position, the distal end of the double-headed needle is positioned within the safety chamber.
[0023] In some embodiments, the shield assembly further includes a flexible hook coupled to the inner surface of the safety chamber, wherein when the shield assembly is in the retracted position, the flexible hook is positioned next to and thus deflected on the needle, and when the shield assembly is in the forward position, the flexible hook is positioned in an undeflected position covering the distal end of the needle.
[0024] In some embodiments, the hub includes a pair of slots formed therein that extend longitudinally along the hub.
[0025] In some embodiments, the shield assembly includes a needle protector coupled to the hub, wherein the needle protector includes: a cylindrical cap portion having a closed distal end having a needle hole formed therein through which a needle can pass; and a pair of fingers extending proximally from the cylindrical cap portion and configured to engage and slide within a pair of slots; wherein the needle protector is rotatable between a locked position preventing proximal movement of the needle protector relative to the hub, and an unlocked position allowing proximal movement of the needle protector relative to the hub, wherein when the needle protector is in the locked position, the pair of fingers are not aligned with the pair of slots, and when the needle protector is in the unlocked position, the pair of fingers are aligned with the pair of slots.
[0026] In some embodiments, each of the port and the needle protector includes a mark thereon to identify whether the rotational position of the needle protector is in the locked position or the unlocked position.
[0027] In some embodiments, the biasing member is positioned between the distal end of the hub and the closed distal end of the needle guard, wherein the biasing member is configured to apply a biasing force to the needle guard, the biasing force biasing the needle guard to the forward position.
[0028] In some embodiments, when the needle protector is in the unlocked position and a proximal thrust greater than the bias force is applied to the needle protector, the needle protector moves from the forward position to the retracted position, and the pair of fingers slides proximally into the pair of slots.
[0029] In some embodiments, when the needle protector is in the locked position, the needle protector can be pressed in the proximal direction to actuate the double-ended needle from the first position to the second position.
[0030] In some embodiments, the biasing member includes a spring configured to transition from a compressed state to an extended state, the spring transitioning from the compressed state to the extended state moving the shield assembly from the retracted position to the forward position. Attached Figure Description
[0031] Figure 1This is a perspective view of an injection device according to a non-limiting embodiment described herein; Figure 2 for Figure 1 An exploded view of the injection device; Figure 3 for Figure 1 A perspective view of the shield assembly included in the injection device; Figure 4 for Figure 3 Side cross-sectional view of the protective shield assembly; Figure 5 for Figure 1 A side view of the injection device, showing the device in its initial state; Figure 6 for Figure 1 A side cross-sectional view of the injection device, wherein the injection device is in the activated state and the shield assembly is in the retracted position; Figure 7 Before first use Figure 1 A side cross-sectional view of the injection device, with the needle cap removed; Figure 8 For first use Figure 1 A side cross-sectional view of the injection device, in which the shield assembly is in the forward position; Figure 9 This is a perspective view of an injection device according to another non-limiting embodiment described herein; Figure 10 for Figure 9 An exploded view of the injection device; Figure 11 for Figure 9 A side view of the injection device, showing the device in its initial state; Figure 12 for Figure 9 A side cross-sectional view of an injection device, wherein the injection device is in an active state and the protective cover assembly of the injection device is in a retracted position; Figure 13 Before first use Figure 9 A side view of the injection device, with the needle cap removed; Figure 14A For first use Figure 9 A side view of the injection device, with the shield assembly in the forward position; Figure 14B For first use Figure 9 A side cross-sectional view of the injection device, in which the shield assembly is in the forward position; Figure 15 This is a perspective view of an injection device according to another non-limiting embodiment described herein; Figure 16 for Figure 15 An exploded view of the injection device; Figure 17 for Figure 15 A side cross-sectional view of the injection device, showing the injection device in its initial state; Figure 18 Before first use Figure 15 A side cross-sectional view of the injection device, wherein the injection device is in an activated state and the protective cover assembly of the injection device is in a locked and forward position; Figure 19 Before first use Figure 15 A side cross-sectional view of the injection device, wherein the injection device is in an activated state and the protective cover assembly of the injection device is in an unlocked and forward position; Figure 20 For initial use Figure 15 A side cross-sectional view of the injection device, in which the shield assembly is pushed proximally to the retracted position; Figure 21 For first use Figure 15 A side cross-sectional view of the injection device, wherein the shield assembly is pushed distally back to the forward position; and Figure 22 For first use Figure 15 A side cross-sectional view of the injection device, in which the shield assembly is in the locked and forward positions. Detailed Implementation
[0032] The following description is provided to enable those skilled in the art to make and use the described embodiments intended for carrying out the invention. However, various modifications, equivalents, variations, and substitutions will still be apparent to those skilled in the art. Any and all such modifications, equivalents, variations, and substitutions are intended to fall within the spirit and scope of the invention.
[0033] In the following text, for descriptive purposes, the terms “upper,” “lower,” “right,” “left,” “vertical,” “horizontal,” “top,” “bottom,” “lateral,” “longitudinal,” and their derivatives shall be used in connection with the present invention as oriented as shown in the accompanying drawings. However, it should be understood that the invention may employ various alternative variations unless explicitly stated otherwise. It should also be understood that the specific devices shown in the accompanying drawings and described in the following specification are merely exemplary embodiments of the invention. Therefore, the specific dimensions and other physical characteristics associated with the embodiments disclosed herein should not be considered limiting.
[0034] As used in this specification, the terms "proximal" and "distal" refer to the directions closer to and further away from the user who places the device in contact with the patient, respectively. Thus, for example, the end of the device that first contacts the patient's body would be the distal end, while the opposite end of the device manipulated by the user would be the proximal end.
[0035] The terms “first,” “second,” etc., are not intended to refer to any particular order or sequence, but rather to different conditions, properties, or elements.
[0036] refer to Figures 1 to 8 This illustration shows a non-limiting embodiment of a pre-filled or pre-charged medical liquid injection device 10 for injecting medication into a patient. The injection device 10 typically includes an end member 12 defining a reservoir 14, an outlet or port 16 in fluid communication with the reservoir 14, a hub 18, a double-ended needle cannula 20 (hereinafter referred to as "needle 20"), a biasing member 22, a shield assembly 24, a guide member 26, and a removable needle cap 28.
[0037] According to various aspects of this disclosure, the end member 12 is configured to include a peripheral region 30 surrounding the reservoir 14. Part or all of the end member 12 may have a laminated construction and be formed of a plurality of films sealed / bonded together. In some embodiments, the end member 12 comprises a laminate consisting of a low-density polyethylene inner film and a cyclic olefin or cyclic olefin copolymer outer film, wherein the inner and outer films are preferably co-extruded and then thermoformed. The peripheral region 30 may be generally flat and is shaped to allow a user to grip the peripheral region while the reservoir 14 is surrounded by the peripheral region 30 and configured as a bulb-shaped reservoir. At least in the region of the bulb-shaped reservoir 14, one or more laminated films forming the end member 12 are formed of a deformable material such that during use of the injection device 10, each of the opposite sides of the bulb-shaped reservoir 14 can be pressed inward to reduce the volume of the reservoir 14. Upon pressing the bulb-shaped reservoir 14, a single dose of medical fluid contained in the bulb-shaped reservoir can be forced out of the reservoir 14 and injected into the patient through the needle 20, as described in further detail below. During the manufacture of the injection device 10, the reservoir 14 can be filled with a filling tube (not shown) in fluid communication with the reservoir 14 and then sealed.
[0038] The port 16 of the injection device 10 is located at the distal end 32 of the end member 12 and is configured as a tubular port, including a puncturable membrane 34 for sealing the reservoir 14. A hub 18 is positioned within and located in the port 16, wherein the hub 18 is configured to retain the needle 20 (i.e., the needle 20 is fixed within a hole formed through the hub 18). The hub 18 may be located within the port 16 such that if sufficient force is applied to the hub 18, the hub can move within the port. That is, when a force is applied to the hub 18, the hub 18 can move proximally rearward and further into the port 16.
[0039] Needle 20 includes a sharp proximal end 36 and an opposing sharp distal end 38 positioned within the internal volume of port 16, the distal end 38 being initially received within (and covered by) needle cap 28. The distal end 38 is used to aspirate or inject medication contained in reservoir 14 into the patient. During use of the injection device 10, the proximal end 36 of needle 20 is received within port 16 but separated from the puncturable membrane 34. In response to a user pushing needle cap 28, the proximal end 36 of needle 20 can be driven through the puncturable membrane 34, thus forcing hub 18 and needle 20 further proximally back into port 16 until the proximal end 36 of needle 20 punctures membrane 34, thereby establishing fluid communication between needle 20 and reservoir 14.
[0040] According to various aspects of this disclosure, as described above, the injection device 10 includes a biasing member 22, a shield assembly 24, and a guide member 26, which, upon injection, collectively cover the distal end 38 of the needle 20. The shield assembly 24 is positioned at the distal end 32 of the end member 12 and is movable distally from a retracted position to an advanced position through sliding interaction with the guide member 26. When the shield assembly 24 is in the retracted position, the distal end 38 of the needle 20 extends distally over the shield assembly 24. When the shield assembly 24 is actuated from the retracted position to the advanced position by the biasing member 22 (e.g., a spring), the distal end 38 of the needle 20 is covered by the shield assembly 24.
[0041] The guide member 26 includes an elongated frame 40, which is coupled to the port 16 and positioned near the distal end 32 of the end member 12. The elongated frame 40 extends across the width of the end member 12 and includes a series of through-holes formed therein, including a first through-hole 42 positioned adjacent to a first edge of the elongated frame 40, a second through-hole 44 positioned adjacent to a second edge of the elongated frame 40, and a third through-hole 46 located at the center of the elongated frame 40 and aligned to receive the port 16 through the third through-hole, wherein a seat 48 is formed around the third through-hole 46 on the distally facing side of the elongated frame 40. Figure 2 and Figures 6 to 8 Each of the first through-hole 42 and the second through-hole 44 includes a radially outwardly extending notch 50 (or opening) formed on its inner surface. The guide member 26 also includes a pair of release protrusions 52 formed on opposite sides of the elongated frame 40 and adjacent to the first through-hole 42 and the second through-hole 44, wherein the release protrusions 52 are aligned with the notches / openings 50 formed in the through-holes 42, 44. The release protrusions 52 can be pressed inward to selectively allow or prevent movement of the shield assembly 24, as explained in further detail below.
[0042] According to various aspects of this disclosure, the shield assembly 24 is configured as a U-shaped sliding member 53, which includes a transverse support 54, a first sliding guide 56, and a second sliding guide 58. The first sliding guide 56 is positioned at a first end of the transverse support 54 and extends proximally from that first end, wherein the first sliding guide 56 is configured to slide through a first through-hole 42 of the guide member 26. The second sliding guide 58 is positioned at a second end of the transverse support 54 and extends proximally from that second end, wherein the second sliding guide 58 is configured to slide through a second through-hole 44 of the guide member 26.
[0043] According to an embodiment, the needle cap connector 60, the receiving portion 62, and the safety chamber 64 are all disposed on the transverse support 54 at the center of the transverse support. The needle cap connector 60 is formed on the distal surface of the transverse support 54 and forms an engagement feature to which the needle cap 28 can be connected. The receiving portion 62 and the safety chamber 64 are formed on the proximal surface of the transverse support 54 and extend proximally from the proximal surface, wherein the receiving portion 62 and the safety chamber 64 are arranged concentrically such that the safety chamber 64 is positioned within the receiving portion 62. The safety chamber 64 is a tubular member including an open proximal end and a closed distal end, and the receiving portion 62 has an open proximal end and a closed distal end. The receiving portion 62 is configured to receive the distal end of the biasing member 22 therein, while the proximal end of the biasing member 22 is held within a seat 48 formed in / on the elongated frame 40. The bias member 22 is therefore positioned between the guide member 26 and the U-shaped sliding member 53 to allow the U-shaped sliding member 53 to translate distally away from the guide member 26 (i.e., from the retracted position to the forward position) when the bias member 22 transitions from the compressed state to the extended state.
[0044] According to an embodiment, each of the first sliding guide 56 and the second sliding guide 58 includes a pair of distal support protrusions 66a, 66b formed near its distal end, and a pair of proximal support protrusions 68a, 68b formed near its proximal end. The support protrusions forming the pair of distal support protrusions 66a, 66b can be configured as rounded, resilient protrusions and can be spaced apart from each other along the length of each sliding guide 56, 58, wherein these protrusions can engage with notches / openings 50 formed in the first through-hole 42 and the second through-hole 44. The support protrusions forming the pair of proximal support protrusions 68a, 68b can be configured as ramp portions including flat end surfaces 70, wherein the flat end surfaces 70 of the protrusions 68a, 68b face each other. The proximal support protrusions 68a, 68b can be spaced apart from each other along the length of each sliding guide 56, 58.
[0045] In some embodiments, the shield assembly 24 may further include a flexible hook 72 coupled to the inner surface of the cylindrical wall forming the safety chamber 64. The flexible hook 72 includes a biased member that is movable between a deflected position and an undeflected position, depending on whether the shield assembly 24 is positioned in a retracted or forward position. When the shield assembly 24 is positioned in the retracted position, the flexible hook 72 is positioned next to the needle 20 and thus deflected. When the shield assembly 24 is in the forward position, the flexible hook 72 is positioned away from the distal end 38 of the needle 20 and is therefore free to move to its undeflected position, where the flexible hook 72 is thus positioned to cover the distal end 38 of the needle 20.
[0046] Now for reference Figures 5 to 8 The operation of the injection device 10 is described in more detail. From the initial configuration of the injection device 10 (e.g....) Figure 5 To begin (as shown), the user will first push the needle cap 28 proximally to establish fluid communication between the needle 20 and the reservoir 14 (as shown). Figure 6 (As shown). When the needle cap 28 is pushed back proximally, the shield assembly 24 is also forced to move back proximally, wherein the first sliding guide 56 and the second sliding guide 58 slide rearward within the through holes 42, 44 of the guide member 26. The proximal movement of the first sliding guide 56 and the second sliding guide 58 forces the nearest protrusion 66a of a pair of distal support protrusions 66a, 66b (on each sliding guide) to disengage from engagement with the corresponding notch / opening 50 in the through holes 42, 44, and the first sliding guide 56 and the second sliding guide 58 continue to move back proximally until the farthest protrusion 66b of a pair of distal support protrusions 66a, 66b (on each sliding guide) engages with the corresponding notch / opening 50 in the through holes 42, 44. This proximal movement of the shield assembly 24 is transmitted to the hub 18 of the retaining needle 20, wherein the proximal end of the safety chamber 64 abuts against the hub 18 and forces the hub to move in the proximal direction. The proximal movement of hub 18 drives the proximal end 36 of needle 20 through puncturable membrane 34 so as to make needle 20 fluidly communicate with reservoir 14.
[0047] like Figure 7 As shown, once the needle 20 is in fluid communication with the reservoir 14, the needle cap 28 can be removed (i.e., detached from the cap connector 60) to prepare for injection of medication into the patient. Once the distal end 38 of the needle 20 is inserted into the patient, the user can press the bulb-shaped reservoir 14 (on both sides of the bulb-shaped reservoir) to force the medication out of the reservoir 14 and through the needle 20, thereby administering it to the patient.
[0048] With the distal end 38 of the needle 20 still inserted in the patient (or immediately inserted after removal from the patient), the user can press and grasp a pair of release protrusions 52 formed on opposite sides of the elongated frame 40 to unlock the shield assembly 24 from the guide member 26. When the release protrusions 52 are pressed, the elastic protrusions 66a, 66b on the first sliding arm 56 and the second sliding arm 58 disengage from the guide member 26, thereby allowing the shield assembly 24 (i.e., the U-shaped sliding member 53) to move from its retracted position to its forward position by causing the biasing member 22 to transition from its compressed state to its extended state. As the injection device 10 (and its needle 20) retracts proximally away from the patient, the biasing member 22 forces the shield assembly 24 distally toward its forward position. Therefore, the shield assembly 24 moves distally toward its forward position until a pair of proximal support protrusions 68a, 68b engage the proximal and distally facing sides of the elongated frame 40, as... Figure 8 As shown. That is, the shield assembly 24 will move distally toward its forward position until the elongated frame 40 moves between a pair of distal support protrusions 66a, 66b, wherein the flat end surface 70 of each of these protrusions engages the proximal and distal surfaces of the elongated frame 40 to lock the shield assembly 24 (i.e., the U-shaped sliding member) in place and prevent conversion back to the retracted position. With the shield assembly 24 in the forward position, the distal end 38 of the needle 20 is positioned within the safety chamber 64, and the flexible hook 72 is positioned away from the distal end 38 of the needle 20 in its undeflected position, thereby covering the distal end 38 of the needle 20.
[0049] Now for reference Figures 9 to 1 4. According to another aspect of this disclosure, an embodiment of an injection device 74 is shown. The injection device 74 generally includes: an end member 12 defining a reservoir 14, a port 76 in fluid communication with the reservoir 14, a hub 18, a double-ended needle 20, a biasing member 22, a shield assembly 78, and a removable needle cap 28.
[0050] As mentioned above Figures 1 to 8 As described in the injection device 10, the end member 12 is configured to include a peripheral region 30 surrounding the reservoir 14. Part or all of the end member 12 may have a laminated construction and be formed of a plurality of membranes sealed / bonded together. The peripheral region 30 may be generally flat and is shaped to allow a user to grasp the peripheral region, while the reservoir 14 is surrounded by the peripheral region 30 and configured as a bulb-shaped reservoir, wherein each of the opposite sides of the bulb-shaped reservoir 14 is configured to be pressed inward during use of the injection device 74 to reduce the volume of the reservoir 14 and force a single dose of medical fluid contained in the reservoir out of the reservoir 14 and through the needle 20 for injection into the patient.
[0051] The port of the injection device 74 is located at the distal end 32 of the end member 12, and the port includes a puncturable membrane 34 therein for sealing the reservoir 14. Figure 12 and Figure 14B According to various aspects of this disclosure, port 76 is configured as a secure port (hereinafter referred to as "secure port 76"), which includes a port body 80 defining a cavity having an open distal end and a proximal end, the proximal end having an end cap 82. The port body 80 also includes a pair of slots 84 formed therein extending longitudinally along the port body, and an opening 86 formed in the port body 80 on a side of the port body at a location between the pair of slots 84. A coupling member 88 is positioned at the proximal end of the port body 80 and configured to couple the secure port 76 to an end member 12, wherein a puncture-resistant membrane 34 sealing the reservoir 14 is positioned in the coupling member 88.
[0052] Hub 18 is positioned within and within safety port 76, wherein hub 18 is configured to retain needle 20 (i.e., needle 20 is secured within a hole formed through hub 18). Hub 18 may be positioned within safety port 76 such that it can be moved within safety port if sufficient force is applied to hub 18. In some embodiments, hub 18 may be moved further proximally back into safety port 76 to a position where needle 20 is in fluid communication with reservoir 14 (i.e., where needle 20 pierces the membrane 34 sealing reservoir 14).
[0053] Needle 20 includes a sharp proximal end 36 and an opposing sharp distal end 38 positioned within the internal volume of safety port 76, the distal end being initially received within (and covered by) needle cap 28. The distal end 38 is used to aspirate or inject medication contained in reservoir 14 into the patient. During use of the injection device 74, the proximal end 36 of needle 20 is received within safety port 76 but separated from the puncturable membrane 34. In response to a user pushing needle cap 28 proximally, the proximal end 36 of needle 20 can be driven through the puncturable membrane 34, thus forcing hub 18 and needle 20 further proximally back into safety port 76 until the proximal end 36 of needle 20 punctures membrane 34, thereby establishing fluid communication between needle 20 and reservoir 14.
[0054] According to various aspects of this disclosure, as described above, the injection device 74 includes a biasing member 22 and a shield assembly 78, which together cover the distal end 38 of the needle 20 after injection. The shield assembly 78 is positioned at the distal end 32 of the end member 12 and is movable distally from a retracted position to an advanced position by sliding interaction with a safety port 76. When the shield assembly 78 is in the retracted position, the distal end 38 of the needle 20 extends distally over the shield assembly 78. When the shield assembly 78 is actuated from the retracted position to the advanced position by the biasing member 22 (e.g., a spring), the distal end 38 of the needle 20 is covered by the shield assembly 78.
[0055] According to various aspects of this disclosure, the shield assembly 78 includes a needle chamber 90 and a pair of side members 92. The needle chamber 90 is locatable within a cavity of a safety port 76 and includes a cylindrical body 94 and a cantilevered flexible protrusion 96 coupled to a distal end of the cylindrical body 94. The cylindrical body 94 has an open proximal end and includes a plurality of slots 98 formed therein extending longitudinally along the cylindrical body, and an annular flange 100 formed at the distal end of the cylindrical body. The annular flange 100 extends radially inward and forms a proximal-facing seat 102 in / on the needle chamber 90. In some embodiments, the distal end of the cylindrical body 94 further includes a distal-facing needle cap connector 104 that provides an engagement feature to which a needle cap 28 can be engaged. A cantilevered flexible protrusion 96 (at its distal end) is coupled to the distal end of a cylindrical body 94, and the cantilevered flexible protrusion 96 includes a release button 105 located thereon (at its proximal end), the release button being sized to be received within an opening 86 of the port body 80. By applying a thrust to the release button 105, the cantilevered flexible protrusion 96 can be radially inwardly pressed / bent to disengage the button 105 from the opening 86 of the port body 80, thereby unlocking the needle chamber from the safety port 76.
[0056] A pair of side members 92 of the shield assembly 78 are configured to movably connect the needle chamber 90 to the safety port 76. Each of the pair of side members 92 includes a pin 106 formed on its inward-facing surface, which engages a pair of slots 84 of the port body 80 and a plurality of slots 98 of the cylindrical body 94 to allow longitudinal movement of the pair of side members 92 and the needle chamber 90 relative to the safety port 76. Each of the pair of side members 92 also includes locking protrusions 108 formed on its inward-facing surface, which engage the pair of slots 84 of the port body 80 and the plurality of slots 98 of the cylindrical body 94 to restrict distal movement of the needle chamber 90 from the safety port 76, thereby preventing excessive slippage and disengagement. In some embodiments, each of these side members 92 includes a top pin 106a and a bottom pin 106b spaced apart in the longitudinal direction, a top locking protrusion 108a (aligned with the top pin), and a pair of bottom locking protrusions 108b spaced apart in the longitudinal direction from the top locking protrusion 108a and spaced apart from each other in the horizontal direction.
[0057] The biasing member 22 is positioned relative to the safety port 76 and the needle chamber 90 to be held between the safety port 76 and the needle chamber 90 and to allow the needle chamber 90 (and side member 92) to translate distally away from the safety port 76 when the biasing member 22 transitions from a compressed state to an extended state (i.e., translating the shield assembly 78 from a retracted position to an extended position). More specifically, the biasing member 22 is held between / by the end cap 82 of the safety port 76 and the seat 102 of the needle chamber 90.
[0058] Now for reference Figures 11 to 1 4. The operation of the injection device 74 is described in more detail. From the initial configuration of the injection device 74 (e.g.) Figure 11 To begin (as shown), the user will first push the needle cap 28 proximally to establish fluid communication between the needle 20 and the reservoir 14 (as shown). Figure 12 (As shown). When the needle cap 28 is pushed back proximally, the shield assembly 78 is also forced back proximally, with the needle chamber 90 pushed back within the safety port 76. This proximal movement of the needle chamber 90 is transmitted to the hub 18 holding the needle 20, with the proximal end of the needle chamber 90 abutting against the hub 18 and forcing the hub to move proximally. This proximal movement of the hub 18 drives the proximal end 36 of the needle 20 through the puncturable membrane 34, thereby establishing fluid communication between the needle 20 and the reservoir 14.
[0059] like Figure 13As shown, once the needle 20 is in fluid communication with the reservoir 14, the needle cap 28 can be removed (i.e., detached from the cap connector 104) to prepare for injection of medication into the patient. Once the distal end 38 of the needle 20 is inserted into the patient, the user can press the bulb-shaped reservoir 14 (on both sides of the bulb-shaped reservoir) to force the medication out of the reservoir 14 and through the needle 20, thereby administering it to the patient.
[0060] With the distal end 38 of the needle 20 still inserted in the patient, the user can press and hold the release button 105 formed on the cantilevered flexible protrusion 96 of the needle chamber 90 to unlock the needle chamber 90 from the safety port 76. When the release button 105 is pressed, the button 105 disengages from the opening 86 of the safety port 76, thereby allowing the shield assembly 78 (i.e., the needle chamber 90 and the side member 92) to move from its retracted position to its forward position by causing the bias member 22 to switch from its compressed state to its extended state. As the injection device 74 (and its needle 20) is withdrawn proximally away from the patient, the bias member 22 forces the shield assembly 78 distally toward its forward position. Therefore, the shield assembly 78 moves distally toward its forward position by sliding the pin 106 of the side member 92 within the slot 98 of the port body 80 and the slot 84 of the cylindrical body 94, until the locking protrusion 108 of the side member 92 reaches the distal end of the slot 98 in the port body 80 and the slot 84 in the cylindrical body 94 (e.g., Figure 14A and Figure 14B (As shown). That is, the shield assembly 78 will move distally toward its forward position until the locking protrusion 108 restricts further movement of the shield assembly and locks the shield assembly 78 (i.e., the needle chamber 90 and the side member 92) in place to prevent conversion back to the retracted position. With the shield assembly 78 in the forward position, the distal end 38 of the double-ended needle 20 is positioned within the needle chamber 90 to cover the distal end 38 of the needle 20.
[0061] Now for reference Figures 15 to 22 According to another aspect of this disclosure, an embodiment of an injection device 110 is shown. The injection device 110 generally includes: an end member 12 defining a reservoir 14, a port 24 in fluid communication with the reservoir 14, a hub 112, a double-ended needle 20, a biasing member 22, and a shield assembly 114.
[0062] As mentioned above Figures 1 to 8 and Figures 9 to 1As described in the injection devices 10, 74, the end member 12 is configured to include a peripheral region 30 surrounding the reservoir 14. Part or all of the end member 12 may have a laminated construction and be formed of a plurality of sealed / bonded membranes. The peripheral region 30 may be generally flat and is shaped to allow a user to grasp it, while the reservoir 14 is surrounded by the peripheral region 30 and configured as a bulb-shaped reservoir, wherein each of the opposite sides of the bulb-shaped reservoir 14 is configured to be pressed inward during use of the injection device 110 to reduce the volume of the reservoir 14 and force a single dose of medical fluid contained in the reservoir out of the reservoir 14 and through the needle 20 for injection into the patient.
[0063] The port 24 of the injection device 110 is located at the distal end 32 of the end member 12 and is configured as a tubular port, which includes a puncturable membrane 34 therein for sealing the reservoir 14. Figures 17 to 22 Hub 112 is positioned within and within port 24, wherein hub 112 is configured to retain needle 20 (i.e., needle 20 is secured within a hole formed through hub 112). Hub 112 may be positioned within port 24 such that it may be movable within the port if sufficient force is applied to hub 112. In some embodiments, hub 112 may be moved further proximally back into port 24 to a position where needle 20 is in fluid communication with reservoir 14 (i.e., where needle 20 pierces the membrane 34 sealing reservoir 14).
[0064] According to various aspects of this disclosure, hub 112 is configured to include a pair of slots 116 formed therein, the pair of slots extending longitudinally along hub 112. The pair of slots 116 may extend on opposite sides / surfaces of hub 112 and over a substantial length of hub 112. The slots 116 may open at the distal end of hub 112 to allow engagement with shroud assembly 114, as explained in further detail below, while the slots 116 may close at the proximal end of hub 112.
[0065] The needle 20 includes a sharp proximal end 36 and an opposing sharp distal end 38 positioned within the internal volume of the port 24, the distal end being initially received within (and covered by) a shield assembly 114. The sharp distal end 38 is used to aspirate or inject medication contained in the reservoir 14 into the patient. During use of the injection device 110, the proximal end 36 of the needle 20 is received within the port 24 but separated from the puncturable membrane 34. In response to a user pushing the shield assembly 114 proximally against the hub 112, the proximal end 36 of the needle 20 can be driven through the puncturable membrane 34, thus pushing the hub 112 and the needle 20 further proximally back into the port 24 until the proximal end 36 of the needle 20 punctures the membrane 34, thereby establishing fluid communication between the needle 20 and the reservoir 14.
[0066] According to various aspects of this disclosure, as described above, the injection device 110 includes a biasing member 22 and a shield assembly 114, which together cover the distal end 38 of the needle 20 after injection. The shield assembly 114 is positioned at the distal end 32 of the end member 12 and is movable between an advancing position and a retracted position by sliding interaction with the hub 112 and the port 24. When the shield assembly 114 is in the retracted position, the distal end 38 of the needle 20 extends distally over the shield assembly 114. When the shield assembly 114 is actuated from the retracted position to the advancing position by the biasing member 22 (e.g., a spring), the distal end 38 of the needle 20 is covered by the shield assembly 114.
[0067] According to various aspects of this disclosure, the shield assembly 114 is configured to be movably coupled to the needle guard 118 of the hub 112. The needle guard 118 may be characterized by generally including a cylindrical cap portion 120 and a pair of fingers 122. The cylindrical cap portion 120 includes an open proximal end 124 and a closed distal end 126, wherein a needle hole 128 is formed in the closed distal end 126 through which a needle 20 can pass. The pair of fingers 122 extend proximally from the cylindrical cap portion 120 and are configured to engage and slide within a pair of slots 116 formed in the hub 112. A biasing member 22 is positioned between the distal end of the hub 112 and the closed distal end 126 of the needle guard 118, wherein the biasing member 22 is configured to apply a biasing force to the needle guard 118, the biasing force biasing the needle guard 118 to an advanced position.
[0068] According to various aspects of this disclosure, the needle protector 118 is rotatable clockwise and / or counterclockwise relative to the hub 112 and port 24, such that the needle protector 118 can rotate between a locked position and an unlocked position. The locked position prevents the needle protector 118 from moving proximally to engage with the hub 112, while the unlocked position allows the needle protector 118 to move proximally to engage with the hub 112. That is, when the needle protector 118 is in the locked position, a pair of fingers 122 are misaligned with a pair of slots 116 in the hub 112, such that the needle protector 118 cannot be actuated to slide the fingers 122 proximally into / within the slots 116 to move the needle protector 118 to its retracted position. When the needle protector 118 is in the unlocked position, a pair of fingers 122 are aligned with a pair of slots 116, such that the needle protector 118 can be actuated to slide the fingers 122 proximally into the slots 116, thereby moving the needle protector 118 to its retracted position.
[0069] In some embodiments, each of port 24 and needle guard 118 includes a mark 130 thereon to identify the rotational position of needle guard 118 relative to hub 112 and port 24. When mark 130 on needle guard 118 is not aligned with the mark on port 24, the operator can see that needle guard 118 is in the locked position. Conversely, when mark 130 on needle guard 118 is aligned with mark 130 on port 24, the operator can see that needle guard 118 is in the unlocked position. In some embodiments, mark 130 on port 24 and mark 130 on needle guard 118 are set as arrows.
[0070] Now for reference Figures 17 to 22 The operation of the injection device 110 is described in more detail. The initial configuration of the injection device 110 (e.g.) Figure 17 As shown, the needle guard 118 is in the forward position, where the needle guard 118 covers the distal end 38 of the needle 20. In the initial configuration, the needle guard 118 is oriented / rotated relative to the hub 112 to be in the locked position.
[0071] When the user wishes to administer medication to a patient using the injection device 110, they will first push the needle guard 118 proximally to establish fluid communication between the needle 20 and the reservoir 14 (e.g., Figure 18 (As shown). When the needle guard 118 is pushed back proximally, the proximal ends of the fingers 122 on the needle guard 118 press against the hub 112, thereby transmitting force to the hub. Further pushing of the needle guard 118 in the proximal direction causes the hub 112 to move proximally within the port 24, thereby driving / propelling the proximal end 36 of the needle 20 through the puncturable membrane 34, thus enabling fluid communication between the needle 20 and the reservoir 14.
[0072] like Figure 19 As shown, once the needle 20 is in fluid communication with the reservoir 14, the needle protector 118 can be rotated from the locked position to the unlocked position in preparation for injecting medication into the patient. As previously described, when the needle protector is rotated to the unlocked position, a pair of fingers 122 on the needle protector 118 are aligned with a pair of slots 116 in the hub 112.
[0073] With the needle protector 118 in the unlocked position, the user can position the injection device 110 near the patient's skin and apply a pushing force to it. When the needle protector 118 is in the unlocked position, and a proximal pushing force (through contact with the skin) greater than the biasing force of the biasing member 22 is applied to the needle protector 118, the needle protector 118 moves from the forward position to the retracted position (e.g., Figure 20As shown), a pair of fingers 122 on the needle protector 118 slide proximally into a pair of slots 116 in the hub 112. Once the distal end 38 of the needle 20 is inserted into the patient, the user can press the bulb-shaped reservoir 14 (on both sides of the bulb-shaped reservoir) to force the medication out of the reservoir 14 and through the needle 20, thereby administering it to the patient.
[0074] When administering medication to a patient, the user can withdraw the injection device 110 (and its needle 20) away from the patient and proximally. For example... Figure 21 As shown, when the injection device 110 is withdrawn away from the patient, the biasing member 22 forces the needle protector 118 from the retracted position to the distal and forward position, wherein the fingers 122 of the needle protector 118 slide within the slot 116 of the hub 112. With the needle protector 118 in the forward position, the distal end 38 of the double-ended needle 20 is again covered by the needle protector 118.
[0075] Once the needle protector 118 reaches the forward position, the user can rotate it from the unlocked position back to the locked position (e.g., Figure 22 (As shown). The needle guard 118 rotates back to its locked position to prevent any subsequent accidental movement of the needle guard 118 from its forward position back to its retracted position, thereby preventing any potential needle pricks.
[0076] Advantageously, the aspects of the disclosure described herein provide a disposable injection device with features that automatically prevent reuse of the device and protect the needle of the device after injection. A shield assembly is provided on the injection device, which is movable from a retracted position to an advanced position, wherein when the shield assembly is in the retracted position, the distal end of the needle extends distally over the shield assembly, and when the shield assembly is in the advanced position, the distal end of the needle is covered by the shield assembly. The shield assembly can be automatically actuated to the advanced position after injection, or can be actuated to the advanced position by the user after injection.
[0077] Although this disclosure has been described in detail for illustrative purposes based on embodiments or aspects currently considered most practical and preferred, it should be understood that such detailed description is for that purpose only, and this disclosure is not limited to the disclosed embodiments or aspects. Rather, this disclosure is intended to cover modifications and equivalent arrangements within the spirit and scope of the appended claims. For example, it should be understood that this disclosure contemplates that, to the extent possible, one or more features of any embodiment may be combined with one or more features of any other embodiment.
Claims
1. A pre-filled injection device, the pre-filled injection device comprising: An end member, the end member being gripped by a user and having a distal end and a proximal end, the end member comprising a membrane; A reservoir, defined within the end member and pre-filled with fluid, wherein the reservoir is at least partially formed by the membrane, which can be pressed by the user to reduce the volume of the reservoir, thereby forcing the fluid out of the reservoir; A port, which is disposed on the end member and at the distal end of the end member and configured to provide an inlet to the reservoir, the port including a hub located therein; A double-ended needle, held by the hub and having a proximal end positioned within the port and a distal end extending from the port, the double-ended needle being movable from a first position to a second position, in the first position, the proximal end being separated from the reservoir, and in the second position, the proximal end being positioned to pierce the reservoir to allow the needle to be in fluid communication with the reservoir; A shield assembly, positioned at the distal end of the end member and movable distally from a retracted position to an advanced position, wherein when the shield assembly is in the retracted position, the distal end of the needle extends distally beyond the shield assembly, and when the shield assembly is in the advanced position, the distal end of the needle is covered by the shield assembly; and A biasing member configured to actuate the shield assembly from the retracted position to the forward position. The hub includes a pair of slots formed therein extending longitudinally along the hub.
2. The pre-filled injection device according to claim 1, further comprising a removable needle cap, the removable needle cap being pressable in a proximal direction to actuate the double-ended needle from the first position to the second position.
3. The pre-filled injection device according to claim 2, wherein, After actuating the double-ended needle from the first position to the second position, the removable needle cap is removed to allow the distal end of the needle to be inserted into the patient.
4. The pre-filled injection device according to claim 2 or 3, wherein, The port includes a secure port, which includes: A port body defining a cavity and having an open distal end and a proximal end, an end cap at the proximal end of the port body, wherein the port body has a pair of slots formed therein extending longitudinally along the port body, and an opening formed in the port body on a side of the port body at a location between the pair of slots; and A connecting member is located at the proximal end of the port body and is configured to connect the security port to the end member.
5. The pre-filled injection device according to claim 4, wherein, The protective shield assembly includes: A needle chamber capable of being positioned within the cavity, the needle chamber comprising: A cylindrical body having an open proximal end, wherein the cylindrical body has a plurality of slots formed therein extending longitudinally along the cylindrical body, and an annular flange formed at the distal end of the cylindrical body, the annular flange extending radially inward and forming a seat; and A cantilevered flexible protrusion connected to the distal end of the cylindrical body, the flexible protrusion having a button located thereon, the button being sized to be received within an opening in the port body; and A pair of side members configured to movably connect the needle chamber to the safety port, each of the pair of side members including a pin and a locking protrusion, the pin and the locking protrusion engaging with a pair of slots of the port body and a plurality of slots of the cylindrical body to enable the pair of side members and the needle chamber to move longitudinally relative to the safety port; The biasing member is positioned between the safety port and the needle chamber and is held by the end cap and the seat. The biasing member is configured to translate the needle chamber distally from the safety port, thereby transferring the shield assembly from the retracted position to the forward position.
6. The pre-filled injection device according to claim 5, wherein, When the flexible protrusion is pressed inward, the button disengages from the opening to unlock the needle chamber from the safety port, thereby releasing the biasing member and allowing the needle chamber to move distally from the safety port.
7. The pre-filled injection device according to claim 5 or 6, wherein, The engagement of the pin with a pair of slots on the port body and a plurality of slots on the cylindrical body restricts the distal movement of the needle chamber from the safety port to prevent excessive slippage.
8. The pre-filled injection device according to any one of claims 5 to 7, wherein, Once the shield assembly is switched to the forward position, the locking protrusion locks the needle chamber in place and prevents it from switching back to the retracted position.
9. The pre-filled injection device according to any one of claims 5 to 8, wherein, The removable needle cap is attached to the distal end of the cylindrical body of the needle chamber.
10. The pre-filled injection device according to claim 2 or 3, further comprising a guide member coupled to the port, the guide member comprising: An elongated frame, attached to the port and extending across the width of the end member, includes a first through-hole positioned adjacent to a first edge of the elongated frame, a second through-hole positioned adjacent to a second edge of the elongated frame, and a third through-hole located at the center of the elongated frame and aligned with the port, wherein a seat is formed around the third through-hole on the distally facing side of the elongated frame; and A pair of release protrusions are formed on opposite sides of the elongated frame and adjacent to the first through hole and the second through hole.
11. The pre-filled injection device according to claim 10, wherein, The protective cover assembly includes a U-shaped sliding member, the U-shaped sliding member comprising: A transverse support having a first end and a second end; A first sliding guide is positioned at a first end of the transverse support and extends proximally from the transverse support, the first sliding guide being configured to slide through the first through hole; A second sliding guide is positioned at the second end of the transverse support and extends proximally from the transverse support, and the second sliding guide is configured to slide through the second through hole; The receiving portion located at the center of the transverse support; and A safety chamber located within the receiving portion, the safety chamber having an open proximal end and an open distal end; The biasing member is positioned between the guide member and the U-shaped sliding member and is held by the seat and the receiving portion. The biasing member is configured to cause the U-shaped sliding member to translate distally away from the guide member, thereby changing the shield assembly from the retracted position to the forward position.
12. The pre-filled injection device according to claim 11, wherein, Each of the first sliding guide and the second sliding guide includes: A pair of distal support protrusions; and A pair of proximal support protrusions; Each of the pair of distal support protrusions is capable of engaging with a notch formed in a corresponding one of the first and second through holes; and The pair of proximal support protrusions are capable of engaging with the proximal side and the distal side of the elongated frame.
13. The pre-filled injection device according to claim 12, wherein, With the shield assembly in the retracted position, one of the pair of distal support protrusions on each of the first and second sliding guides engages with a recess in a corresponding one of the first and second through holes to lock the U-shaped sliding member in the retracted position.
14. The pre-filled injection device according to claim 13, wherein, When the pair of release protrusions are pressed inward, one of the pair of distal support protrusions on each of the first and second sliding guide buttons disengages from the notch to unlock the U-shaped sliding member from the guide member, thereby releasing the bias member and allowing the U-shaped sliding member to move distally away from the guide member.
15. The pre-filled injection device according to any one of claims 12 to 14, wherein, With the shield assembly in the forward position, the pair of proximal support protrusions engage with the proximal and distal sides of the elongated frame to lock the U-shaped sliding member in place and prevent it from reverting to the retracted position.
16. The pre-filled injection device according to any one of claims 11 to 15, wherein, With the protective shield assembly in the forward position, the distal end of the double-headed needle is positioned within the safety chamber.
17. The pre-filled injection device according to any one of claims 12 to 16, wherein, The shield assembly also includes a flexible hook coupled to the inner surface of the safety chamber, wherein when the shield assembly is in the retracted position, the flexible hook is positioned next to and thus deflected by the needle, and when the shield assembly is in the forward position, the flexible hook is positioned in an undeflected position covering the distal end of the needle.
18. The pre-filled injection device according to claim 1, wherein, The shield assembly includes a needle protector coupled to the hub, the needle protector comprising: A cylindrical cap portion having a closed distal end, the closed distal end including a pinhole formed therein through which a needle can pass; and A pair of fingers extending proximally from the cylindrical cap portion and configured to engage within and slide within the pair of slots; The needle protector is rotatable between a locked position and an unlocked position. The locked position prevents the needle protector from moving proximally relative to the hub, while the unlocked position allows the needle protector to move proximally relative to the hub. When the needle protector is in the locked position, the pair of fingers are not aligned with the pair of slots, while when the needle protector is in the unlocked position, the pair of fingers are aligned with the pair of slots.
19. The pre-filled injection device according to claim 18, wherein, Each of the port and the needle protector includes a mark thereon to identify whether the rotational position of the needle protector is in the locked position or the unlocked position.
20. The pre-filled injection device according to any one of claims 19, wherein, The biasing member is positioned between the distal end of the hub and the closed distal end of the needle guard, and the biasing member is configured to apply a biasing force to the needle guard, the biasing force biasing the needle guard to the forward position.
21. The pre-filled injection device according to claim 20, wherein, When the needle protector is in the unlocked position and a proximal thrust greater than the bias force is applied to the needle protector, the needle protector moves from the forward position to the retracted position, and the pair of fingers slide proximal into the pair of slots.
22. The pre-filled injection device according to any one of claims 18, wherein, When the needle protector is in the locked position, the needle protector can be pressed in the proximal direction to actuate the double-ended needle from the first position to the second position.
23. The pre-filled injection device according to any one of claims 1 to 22, wherein, The biasing member includes a spring configured to transition from a compressed state to an extended state, the spring transitioning from the compressed state to the extended state to move the shield assembly from the retracted position to the forward position.
